1 |
McKinley KL, Longaker MT, Naik S. Emerging frontiers in regenerative medicine[J]. Science, 2023, 380(6647):796-798.
|
2 |
Vasanthan J, Gurusamy N, Rajasingh S, et al. Role of human mesenchymal stem cells in regenerative therapy[J]. Cells, 2020, 10(1):54. doi: 10.3390/cells10010054.
|
3 |
Yang X, Meng Y, Han Z, et al. Mesenchymal stem cell therapy for liver disease: full of chances and challenges[J]. Cell Biosci, 2020, 10:123. doi: 10.1186/s13578-020-00480-6.
|
4 |
Malekpour K, Hazrati A, Zahar M, et al. The potential use of mesenchymal stem cells and their derived exosomes for orthopedic diseases treatment[J]. Stem Cell Rev Rep, 2022, 18(3):933-951.
|
5 |
García-Bernal D, García-Arranz M, Yáñez RM, et al. The current status of mesenchymal stromal cells: controversies, unresolved issues and some promising solutions to improve their therapeutic efficacy[J]. Front Cell Dev Biol, 2021, 9:650664. doi: 10.3389/fcell.2021.650664.
|
6 |
Caplan H, Olson SD, Kumar A, et al. Mesenchymal stromal cell therapeutic delivery: translational challenges to clinical application[J]. Front Immunol, 2019, 10:1645. doi: 10.3389/fimmu.2019.01645.
|
7 |
Ren Z, Qi Y, Sun S, et al. Mesenchymal stem cell-derived exosomes: hope for spinal cord injury repair[J]. Stem Cells Dev, 2020, 29(23):1467-4778.
|
8 |
Friedenstein AJ, Chailakhyan RK, Latsinik NV, et al. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo[J]. Transplantation, 1974, 17(4):331-340.
|
9 |
Zhou J, Shi Y. Mesenchymal stem/stromal cells (MSCs): origin, immune regulation, and clinical applications[J]. Cell Mol Immunol, 2023, 20(6):555-557.
|
10 |
Tsai AC, Jeske R, Chen X, et al. Influence of microenvironment on mesenchymal stem cell therapeutic potency: from planar culture to microcarriers[J]. Front Bioeng Biotechnol, 2020, 8:640. doi: 10.3389/fbioe.2020.00640.
|
11 |
Kemp KC, Hows J, Donaldson C. Bone marrow-derived mesenchymal stem cells[J]. Lymphoma, 2005, 46(11):1531-1544.
|
12 |
Wang L, Tran I, Seshareddy K, et al. A comparison of human bone marrow–derived mesenchymal stem cells and human umbilical cord–derived mesenchymal stromal cells for cartilage tissue engineering[J]. Tissue Eng Part A, 2009, 15(8):2259-2266.
|
13 |
Konno M, Hamabe A, Hasegawa S, et al. Adipose-derived mesenchymal stem cells and regenerative medicine[J]. Dev Growth Differ, 2013, 55(3):309-318.
|
14 |
Ouryazdanpanah N, Dabiri S, Derakhshani A, et al. Peripheral blood-derived mesenchymal stem cells: growth factor-free isolation, molecular characterization and differentiation[J]. Iran J Pathol, 2018, 13(4):461-466.
|
15 |
Wang Y, Yu X, Chen E, et al. Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases[J]. Stem Cell Res Ther, 2016, 7(1):71. doi: 10.1186/s13287-016-0330-3.
|
16 |
De Sousa EB, Casado PL, Neto VM, et al. Synovial fluid and synovial membrane mesenchymal stem cells: latest discoveries and therapeutic perspectives[J]. Stem Cell Res Ther, 2014, 5(5):112. doi: 10.1186/scrt501.
|
17 |
Li Z, Jiang CM, An S, et al. Immunomodulatory properties of dental tissue-derived mesenchymal stem cells[J]. Oral Diseases, 2014, 20(1):25-34.
|
18 |
Alanazi A, Munir H, Alassiri M, et al. Comparative adhesive and migratory properties of mesenchymal stem cells from different tissues[J]. Biorheology, 2019, 56(1):15-30.
|
19 |
Merimi M, El-Majzoub R, Lagneaux L, et al. The Therapeutic potential of mesenchymal stromal cells for regenerative medicine: current knowledge and future understandings[J]. Front Cell Dev Biol, 2021, 9:661532. doi: 10.3389/fcell.2021.661532.
|
20 |
Margiana R, Markov A, Zekiy AO, et al. Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review[J]. Stem Cell Res Ther, 2022, 13(1):366. doi: 10.1186/s13287-022-03054-0.
|
21 |
Costela-Ruiz VJ, Melguizo-Rodríguez L, Bellotti C, et al. Different sources of mesenchymal stem cells for tissue regeneration: a guide to identifying the most favorable one in orthopedics and dentistry applications[J]. Int J Mol Sci, 2022, 23(11):6356. doi: 10.3390/ijms23116356.
|
22 |
Han Y, Li X, Zhang Y, et al. Mesenchymal stem cells for regenerative medicine[J]. Cells, 2019, 8(8):886. doi: 10.3390/cells8080886.
|
23 |
Fernández-Santos ME, Garcia-Arranz M, Andreu EJ, et al. Optimization of mesenchymal stromal cell (MSC) manufacturing processes for a better therapeutic outcome[J]. Front Immunol, 2022, 13:918565. doi: 10.3389/fimmu.2022.918565.
|
24 |
Wu M, Zhang R, Zou Q, et al. Comparison of the biological characteristics of mesenchymal stem cells derived from the human placenta and umbilical cord[J]. Scientific reports, 2018, 8(1):5014. doi: 10.1038/s41598-018-23396-1.
|
25 |
Yanuar A, Agustina H, Antarianto RD, et al. Extracellular vesicles from adipose-derived mesenchymal stem cells improve ligament-bone integration after anterior cruciate ligament primary repair in rabbit[J]. Biomolecules, 2025, 15(3):396. doi: 10.3390/biom15030396.
|
26 |
Tian L, Wang Z, Chen S, et al. Ellagic acid-loaded sEVs encapsulated in GelMA hydrogel accelerate diabetic wound healing by activating EGFR on skin repair cells[J]. Cell proliferation, 2025, 19:e70064. doi: 10.1111/cpr.70064.
|
27 |
Xu M, Diao L, Xu X, et al. Proteins from stressed mesenchymal stem cells can repair hair follicles and promote hair regeneration[J]. ACS Pharmacol Transl Sci, 2025, 8(6):1768-1777.
|
28 |
Gao X, Chen Y, Wang J, et al. Mitochondria-rich extracellular vesicles from bone marrow stem cells mitigate muscle degeneration in rotator cuff tears in a rat model through macrophage M2 phenotype conversion[J]. Arthroscopy, 2025, 25:S0749-8063(25)00229-4.
|
29 |
Huang J, Shi L, Yang Y, et al. Mesenchymal cell-derived exosomes and miR-29a-3p mitigate renal fibrosis and vascular rarefaction after renal ischemia reperfusion injury[J]. Stem Cell Res Ther, 2025, 16(1):135. doi: 10.1186/s13287-025-04226-4.
|
30 |
Li P. Comparative breakthrough: umbilical cord mesenchymal stem cells vs bone marrow mesenchymal stem cells in heart failure treatment[J]. World J Cardiol, 2024, 16(12):776-780.
|
31 |
Shi X, Zhang K, Qi Q, et al. Human umbilical cord-derived mesenchymal stem cells attenuate hepatic stellate cells activation and liver fibrosis[J]. Molecular Biology Reports, 2024, 51(1):734. doi: 10.1007/s11033-024-09664-6.
|
32 |
Pellegrini G, Ardigò D, Milazzo G, et al. Navigating market authorization:the path Holoclar took to become the first stem cell product approved in the European Union[J]. Stem Cells Transl Med, 2018, 7(1):146-154.
|
33 |
Kawatani K, Omana Suarez G, Perkerson RB, et al. Human iPSC-derived MSCs induce neurotrophic effects and improve metabolic activity in acute neuronal injury models[J]. J Neurosci, 2025, 45(1):e0606242024. doi: 10.1523/JNEUROSCI.0606-24.2024.
|
34 |
Wang M, Hao Y, He W, et al. Nebulized mesenchymal stem cell-derived exosomes attenuate airway inflammation in a rat model of chronic obstructive pulmonary disease[J]. Cell Immunol, 2025, 409-410:104933. doi: 10.1016/j.cellimm.2025.104933.
|
35 |
Liu S, Liu W, Liu Y, et al. Repair effect of adipose-derived mesenchymal stem cell-conditioned medium on cyclophosphamide-induced ovarian injury in mice[J]. Reprod Toxicol, 2025, 135:108923. doi: 10.1016/j.reprotox.2025.108923.
|
36 |
Zhao J, Zhou YH, Zhao YQ, et al. Oral cavity-derived stem cells and preclinical models of jaw-bone defects for bone tissue engineering[J]. Stem Cell Res Ther, 2023, 14(1):39. doi: 10.1186/s13287-023-03265-z.
|
37 |
Xue N, Ding X, Huang R, et al. Bone tissue engineering in the treatment of bone defects[J]. Pharmaceuticals (Basel), 2022, 15(7):879. doi: 10.3390/ph15070879.
|
38 |
Aghebati-Maleki L, Dolati S, Zandi R, et al. Prospect of mesenchymal stem cells in therapy of osteoporosis: a review[J]. J Cell Physiol, 2019, 234(6):8570-8578.
|
39 |
Tanaka K, Ogino R, Yamakawa S, et al. Role and function of mesenchymal stem cells on fibroblast in cutaneous wound healing[J]. Biomedicines, 2022, 10(6):1391. doi: 10.3390/biomedicines10061391.
|
40 |
Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors[J].Ciba Found Symp, 1988, 136:42-60.
|
41 |
Claros S, Rico-Llanos GA, Becerra J, et al. A novel human TGF-β1 fusion protein in combination with rhBMP-2 increases chondro-osteogenic differentiation of bone marrow mesenchymal stem cells[J]. Int J Mol Sci, 2014, 15(7):11255-11274.
|
42 |
Kohno Y, Lin T, Pajarinen J, et al. Osteogenic ability of rat bone marrow concentrate is at least as efficacious as mesenchymal stem cells in vitro[J]. J Biomed Mater Res B Appl Biomater, 2019, 107(8):2500-2506.
|
43 |
Khorasani HR, Sanchouli M, Mehrani J, et al. Potential of bone-marrow-derived mesenchymal stem cells for maxillofacial and periodontal regeneration: a narrative review[J]. Int J Dent, 2021, 2021:4759492. doi: 10.1155/2021/4759492.
|
44 |
Kargozar S, Mozafari M, Hashemian SJ, et al. Osteogenic potential of stem cells-seeded bioactive nanocomposite scaffolds: a comparative study between human mesenchymal stem cells derived from bone, umbilical cord Wharton's jelly, and adipose tissue[J]. J Biomed Mater Res B Appl Biomater, 2018, 106(1):61-72.
|
45 |
Yang J, Zhang YS, Yue K, et al. Cell-laden hydrogels for osteochondral and cartilage tissue engineering[J]. Acta Biomaterialia, 2017, 57:1-25.
|
46 |
Torres-Torrillas M, Rubio M, Damia E, et al. Adipose-derived mesenchymal stem cells: a promising tool in the treatment of musculoskeletal diseases[J]. Int J Mol Sci, 2019, 20(12):3105. doi: 10.3390/ijms20123105.
|
47 |
Shin S, Lee J, Kwon Y, et al. Comparative proteomic analysis of the mesenchymal stem cells secretome from adipose, bone marrow, placenta and Wharton's jelly[J]. Int J Mol Sci, 2021, 22(2):845. doi: 10.3390/ijms22020845.
|
48 |
Bunnell BA. Adipose tissue-derived mesenchymal stem cells[J] Cells, 2021, 10(12):3433. doi: 10.3390/cells10123433.
|
49 |
Liao HT, Chen CT. Osteogenic potential: comparison between bone marrow and adipose-derived mesenchymal stem cells[J]. World J Stem Cells, 2014, 6(3):288-295.
|
50 |
Westhauser F, Senger AS, Reible B, et al. In vivo models for the evaluation of the osteogenic potency of bone substitutes seeded with mesenchymal stem cells of human origin: a concise review[J]. Tissue Eng Part C Methods, 2017, 23(12):881-888.
|
51 |
Tang D, Tare RS, Yang LY, et al. Biofabrication of bone tissue: approaches, challenges and translation for bone regeneration[J]. Biomaterials, 2016, 83:363-382.
|
52 |
Khojasteh A, Fahimipour F, Jafarian M, et al. Bone engineering in dog mandible: coculturing mesenchymal stem cells with endothelial progenitor cells in a composite scaffold containing vascular endothelial growth factor[J]. J Biomed Mater Res B Appl Biomater, 2017, 105(7):1767-1777.
|
53 |
Gjerde C, Mustafa K, Hellem S, et al. Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial[J]. Stem Cell Res Ther, 2018, 9(1):213. doi: 10.1186/s13287-018-0951-9.
|
54 |
Katagiri W, Watanabe J, Toyama N, et al. Clinical study of bone regeneration by conditioned medium from mesenchymal stem cells after maxillary sinus floor elevation[J].Implant Dent, 2017, 26(4):607-612.
|
55 |
Awidi A, Al Shudifat A, El Adwan N, et al. Safety and potential efficacy of expanded mesenchymal stromal cells of bone marrow and umbilical cord origins in patients with chronic spinal cord injuries: a phase I/II study[J]. Cytotherapy, 2024, 26(8):825-831.
|
56 |
Ismail HD, Phedy P, Kholinne E, et al. Mesenchymal stem cell implantation in atrophic nonunion of the long bones[J]. Bone Joint Res, 2016, 5(7):287-293.
|
57 |
Al-Najar M, Khalil H, Al-Ajlouni J, et al. Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study[J]. J Orthop Surg Res, 2017, 12(1):190. doi: 10.1186/s13018-017-0689-6.
|
58 |
Tiwari N, Osorio-Blanco ER, Sonzogni A, et al. Nanocarriers for skin applications: where do we stand?[J]. Angew Chem Int Ed Engl, 2022, 61(3):e202107960. doi: 10.1002/anie.202107960.
|
59 |
Chambers ES, Vukmanovic-Stejic M. Skin barrier immunity and ageing[J]. Immunology, 2020, 160(2):116-125.
|
60 |
Yan C, Xv Y, Lin Z, et al. Human umbilical cord mesenchymal stem cell-derived exosomes accelerate diabetic wound healing via ameliorating oxidative stress and promoting angiogenesis[J]. Front Bioeng Biotechnol, 2022, 10:829868. doi: 10.3389/fbioe.2022.829868.
|
61 |
Sun J, Zhang Y, Song X, et al. The healing effects of conditioned medium derived from mesenchymal stem cells on radiation-induced skin wounds in rats[J]. Cell Transplantation, 2018, 28(1):105-115.
|
62 |
Ding J, Wang X, Chen B, et al. Exosomes derived from human bone marrow mesenchymal stem cells stimulated by deferoxamine accelerate cutaneous wound healing by promoting angiogenesis[J]. Biomed Res Int, 2019, 2019:9742765. doi: 10.1155/2019/9742765.
|
63 |
Tutuianu R, Rosca A-M, Albu Kaya MG, et al. Mesenchymal stromal cell-derived factors promote the colonization of collagen 3D scaffolds with human skin cells[J]. J Cell Mol Med, 2020, 24(17):9692-9704.
|
64 |
Joseph A, Baiju I, Bhat IA, et al. Mesenchymal stem cell-conditioned media: a novel alternative of stem cell therapy for quality wound healing[J]. J Cell Physiol, 2020, 235(7-8):5555-5569.
|
65 |
Zhang C, Wang T, Zhang L, et al. Combination of lyophilized adipose-derived stem cell concentrated conditioned medium and polysaccharide hydrogel in the inhibition of hypertrophic scarring[J]. Stem Cell Res Ther, 2021, 12(1):23. doi: 10.1186/s13287-020-02061-3.
|
66 |
Kim GB, Shon OJ, Seo MS, et al. Mesenchymal stem cell-derived exosomes and their therapeutic potential for osteoarthritis[J]. Biology (Basel), 2021, 10(4):285. doi: 10.3390/biology10040285.
|
67 |
Yin S, Ji C, Wu P, et al. Human umbilical cord mesenchymal stem cells and exosomes: bioactive ways of tissue injury repair[J]. Am J Transl Res, 2019, 11(3):1230-1240.
|
68 |
Driscoll J, Patel T. The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease[J]. J Gastroenterol, 2019, 54(9):763-773.
|
69 |
Chang C, Yan J, Yao Z, et al. Effects of mesenchymal stem cell-derived paracrine signals and their delivery strategies[J]. Adv Healthc Mater, 2021, 10(7):e2001689. doi: 10.1002/adhm.202001689.
|
70 |
Asgarpour K, Shojaei Z, Amiri F, et al. Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages[J]. Cell Commun Signal, 2020, 18(1):149. doi: 10.1186/s12964-020-00650-6.
|
71 |
Krawczenko A, Bielawska-Pohl A, Paprocka M, et al. Microvesicles from human immortalized cell lines of endothelial progenitor cells and mesenchymal stem/stromal cells of adipose tissue origin as carriers of bioactive factors facilitating angiogenesis[J]. Stem Cells Int, 2020, 2020:1289380. doi: 10.1155/2020/1289380.
|
72 |
Maacha S, Sidahmed H, Jacob S, et al. Paracrine mechanisms of mesenchymal stromal cells in angiogenesis[J]. Stem cells international, 2020, 2020:4356359. doi: 10.1155/2020/4356359.
|
73 |
Zhu Z, Zhang X, Hao H, et al. Exosomes derived from umbilical cord mesenchymal stem cells treat cutaneous nerve damage and promote wound healing[J]. Front Cell Neurosci, 2022, 16:913009. doi: 10.3389/fncel.2022.913009.
|
74 |
Ntege EH, Sunami H, Shimizu Y. Advances in regenerative therapy: a review of the literature and future directions[J]. Regenerative Therapy, 2020, 14:136-153.
|
75 |
Charles-de-Sá L, Gontijo-de-Amorim NF, Rigotti G, et al. Photoaged skin therapy with adipose-derived stem cells[J]. Plast Reconstr Surg, 2020, 145(6):1037e-1049e.
|
76 |
Zhang C, Huang L, Wang X, et al. Topical and intravenous administration of human umbilical cord mesenchymal stem cells in patients with diabetic foot ulcer and peripheral arterial disease: a phase I pilot study with a 3-year follow-up[J]. Stem Cell Res Ther, 2022, 13(1):451. doi: 10.1186/s13287-022-03143-0.
|
77 |
Levin A, Tonelli M, Bonventre J, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy[J]. Lancet, 2017, 390(10105):1888-1917.
|
78 |
Li J-S, Li B. Renal injury repair: how about the role of stem cells[J]. Adv Exp Med Biol, 2019, 1165:661-670.
|
79 |
Lentine KL, Kasiske BL, Levey AS, et al. Summary of kidney disease: improving global outcomes (KDIGO) clinical practice guideline on the evaluation and care of living kidney donors[J]. Transplantation, 2017, 101(8):1783-1792.
|
80 |
Fraser SDS, Roderick PJ. Kidney disease in the global burden of disease study 2017[J]. Nat Rev Nephrol, 2019, 15(4):193-194.
|
81 |
Susantitaphong P, Cruz DN, Cerda J, et al. World incidence of AKI: a meta-analysis[J]. Clin J Am Soc Nephrol, 2013, 8(9):1482-1493.
|
82 |
Ronco C, Bellomo R, Kellum JA. Acute kidney injury[J]. Lancet, 2019, 394(10212):1949-1964.
|
83 |
Lu Y, Wang L, Zhang M, et al. Mesenchymal stem cell-derived small extracellular vesicles: a novel approach for kidney disease treatment[J]. Int J Nanomedicine, 2022, 17:3603-3618.
|
84 |
Steen EH, Wang X, Balaji S, et al. The role of the anti-inflammatory cytokine interleukin-10 in tissue fibrosis[J]. Adv Wound Care, 2020, 9(4):184-198.
|
85 |
Marbun MBH, Septiana D, Shatri H, et al. Factors affecting the quality of life of patients after kidney transplantation: a cross-sectional study[J]. Acta Med Indones, 2023, 55(2):187-193.
|
86 |
Fazekas B, Griffin MD. Mesenchymal stromal cell–based therapies for acute kidney injury: progress in the last decade[J]. Kidney Int, 2020, 97(6):1130-1140.
|
87 |
Lee JH, Ha DH, Go H-k, et al. Reproducible large-scale isolation of exosomes from adipose tissue-derived mesenchymal stem/stromal cells and their application in acute kidney injury[J]. Int J Mol Sci, 2020, 21(13):4774. doi: 10.3390/ijms21134774.
|
88 |
Fu Z, Zhang Y, Geng X, et al. Optimization strategies of mesenchymal stem cell-based therapy for acute kidney injury[J]. Stem Cell Res Ther, 2023, 14(1):116. doi: 10.1186/s13287-023-03351-2.
|
89 |
Swaminathan M, Kopyt N, Atta MG, et al. Pharmacological effects of Ex vivo mesenchymal stem cell immunotherapy in patients with acute kidney injury and underlying systemic inflammation[J]. Stem Cells Transl Med, 2021, 10(12):1588-1601.
|
90 |
Cao J, Wang B, Tang T, et al. Three-dimensional culture of MSCs produces exosomes with improved yield and enhanced therapeutic efficacy for cisplatin-induced acute kidney injury[J]. Stem Cell Res Ther, 2020, 11(1):206. doi: 10.1186/s13287-020-01719-2.
|
91 |
Tögel FE, Westenfelder C. Kidney protection and regeneration following acute injury: progress through stem cell therapy[J]. Am J Kidney Dis, 2012, 60(6):1012-1022.
|
92 |
Saad A, Dietz AB, Herrmann SMS, et al. Autologous mesenchymal stem cells increase cortical perfusion in renovascular disease[J]. J Am Soc Nephrol, 2017, 28(9):2777-2785.
|
93 |
Wong CY. Current advances of stem cell-based therapy for kidney diseases[J]. World J Stem Cells, 2021, 13(7):914-933.
|
94 |
Ullah M, Liu DD, Thakor AS. Mesenchymal stromal cell homing: mechanisms and strategies for improvement[J]. iScience, 2019, 15:421-438.
|
95 |
王依婷,江杰,马丽, 等. 间充质干细胞及其衍生物对供肝修复的潜在价值[J]. 器官移植, 2023, 14(4):592-597.
|
96 |
Fang X, Liu L, Dong J, et al. A study about immunomodulatory effect and efficacy and prognosis of human umbilical cord mesenchymal stem cells in patients with chronic hepatitis B-induced decompensated liver cirrhosis[J]. J Gastroenterol Hepatol, 2018, 33(4):774-780.
|
97 |
Yagi S, Hirata M, Miyachi Y, et al. Liver regeneration after hepatectomy and partial liver transplantation[J]. Int J Mol Sci, 2020, 21(21):8414. doi: 10.3390/ijms21218414.
|
98 |
Kang SH, Kim MY, Eom YW, et al. Mesenchymal stem cells for the treatment of liver disease: present and perspectives[J]. Gut Liver, 2020, 14(3):306-315.
|
99 |
Husein AL, Liem IK. Pathomechanism of liver fibrosis and mesenchymal stem cells in its resolution process[J]. Open Access Maced J Med Sci, 2023, 11(F):86-94.
|
100 |
Hu C, Zhao L, Duan J, et al. Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis[J]. J Cell Mol Med, 2019, 23(3):1657-1670.
|
101 |
Lee C, Kim M, Han J, et al. Mesenchymal stem cells influence activation of hepatic stellate cells, and constitute a promising therapy for liver fibrosis[J]. Biomedicines, 2021, 9(11):1598. doi: 10.3390/biomedicines9111598.
|
102 |
李明颖,赵春亭,崔渤莉,等.脐血间充质干细胞对白血病细胞增殖和凋亡的影响及其机制[J].中国实验血液学杂志, 2017, 25(3):896-903.
|
103 |
Nevens F, van der Merwe S. Mesenchymal stem cell transplantation in liver diseases[J]. Semin Liver Dis, 2022, 42(3):283-292.
|
104 |
Xu L, Gong Y, Wang B, et al. Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells[J]. J Gastroenterol Hepatol, 2014, 29(8):1620-1628.
|
105 |
Jang YO, Kim YJ, Baik SK, et al. Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study[J]. Liver Int, 2014, 34(1):33-41.
|
106 |
Wang L, Han Q, Chen H, et al. Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis[J]. Stem Cells Dev, 2014, 23(20):2482-2489.
|
107 |
Xie Q, Liu R, Jiang J, et al. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?[J]. Stem Cell Res Ther, 2020, 11(1):519. doi: 10.1186/s13287-020-02011-z.
|
108 |
Soltani L, Mahdavi AH. Role of signaling pathways during cardiomyocyte differentiation of mesenchymal stem cells[J]. Cardiology, 2022, 147(2):216-224.
|
109 |
Mathiasen AB, Qayyum AA, Jørgensen E, et al. Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4-year follow-up of the MSC-HF trial[J]. Eur J Heart Fail, 2020, 22(5):884-892.
|
110 |
Florea V, Rieger AC, DiFede DL, et al. Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT Study)[J]. Circ Res, 2017, 121(11):1279-1290.
|
111 |
Ning Y, Huang P, Chen G, et al. Atorvastatin-pretreated mesenchymal stem cell-derived extracellular vesicles promote cardiac repair after myocardial infarction via shifting macrophage polarization by targeting microRNA-139-3p/Stat1 pathway[J]. BMC Medicine, 2023, 21(1):96. doi: 10.1186/s12916-023-02778-x.
|
112 |
Kozlowska U, Krawczenko A, Futoma K, et al. Similarities and differences between mesenchymal stem/progenitor cells derived from various human tissues[J]. World J Stem Cells, 2019, 11(6):347-374.
|
113 |
Prager P, Kunz M, Ebert R, et al. Mesenchymal stem cells isolated from the anterior cruciate ligament: characterization and comparison of cells from young and old donors[J]. Knee Surg Relat Res, 2018, 30(3):193-205. doi: 10.5792/ksrr.17.067.
|
114 |
García-Muñoz E, Vives J. Towards the standardization of methods of tissue processing for the isolation of mesenchymal stromal cells for clinical use[J]. Cytotechnology, 2021, 73(3):513-522.
|
115 |
Confalonieri D, Schwab A, Walles H, et al. Advanced therapy medicinal products: a guide for bone marrow-derived MSC application in bone and cartilage tissue engineering[J]. Tissue Eng Part B Rev, 2017, 24(2):155-169.
|
116 |
Sandvig I, Gadjanski I, Vlaski-Lafarge M, et al. Strategies to enhance implantation and survival of stem cells after their injection in ischemic neural tissue[J]. Stem Cells Dev, 2017, 26(8):554-565.
|
117 |
De Becker A, Riet IV. Homing and migration of mesenchymal stromal cells: how to improve the efficacy of cell therapy?[J]. World J Stem Cells, 2016, 8(3):73-87.
|
118 |
刘姝岑,朱雪红,宾力,等.间充质干细胞在子宫内膜损伤修复中的机制研究进展[J].江苏大学学报(医学版),2023,33(1):84-92.
|
119 |
Bhat S, Viswanathan P, Chandanala S, et al. Expansion and characterization of bone marrow derived human mesenchymal stromal cells in serum-free conditions[J]. Sci Rep, 2021, 11(1):3403. doi: 10.1038/s41598-021-83088-1.
|
120 |
Zhidu S, Ying T, Rui J, et al. Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities[J]. Stem Cell Res Ther, 2024, 15(1):266. doi: 10.1186/s13287-024-03885-z.
|
121 |
Ramesh S, Govarthanan K, Ostrovidov S, et al. Cardiac differentiation of mesenchymal stem cells: impact of biological and chemical inducers[J]. Stem Cell Rev Rep, 2021, 17(4):1343-1461.
|